1. Home
  2. ERNA vs BOF Comparison

ERNA vs BOF Comparison

Compare ERNA & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERNA
  • BOF
  • Stock Information
  • Founded
  • ERNA 2018
  • BOF 2017
  • Country
  • ERNA United States
  • BOF United States
  • Employees
  • ERNA N/A
  • BOF N/A
  • Industry
  • ERNA Biotechnology: Pharmaceutical Preparations
  • BOF Packaged Foods
  • Sector
  • ERNA Health Care
  • BOF Consumer Staples
  • Exchange
  • ERNA Nasdaq
  • BOF Nasdaq
  • Market Cap
  • ERNA 15.8M
  • BOF 15.1M
  • IPO Year
  • ERNA N/A
  • BOF 2023
  • Fundamental
  • Price
  • ERNA $0.31
  • BOF $1.91
  • Analyst Decision
  • ERNA
  • BOF
  • Analyst Count
  • ERNA 0
  • BOF 0
  • Target Price
  • ERNA N/A
  • BOF N/A
  • AVG Volume (30 Days)
  • ERNA 662.5K
  • BOF 140.5K
  • Earning Date
  • ERNA 03-13-2025
  • BOF 04-01-2025
  • Dividend Yield
  • ERNA N/A
  • BOF N/A
  • EPS Growth
  • ERNA N/A
  • BOF N/A
  • EPS
  • ERNA N/A
  • BOF N/A
  • Revenue
  • ERNA $598,000.00
  • BOF $6,489,951.00
  • Revenue This Year
  • ERNA N/A
  • BOF N/A
  • Revenue Next Year
  • ERNA N/A
  • BOF N/A
  • P/E Ratio
  • ERNA N/A
  • BOF N/A
  • Revenue Growth
  • ERNA 1072.55
  • BOF 372.36
  • 52 Week Low
  • ERNA $0.22
  • BOF $0.61
  • 52 Week High
  • ERNA $2.63
  • BOF $4.11
  • Technical
  • Relative Strength Index (RSI)
  • ERNA 44.59
  • BOF 39.91
  • Support Level
  • ERNA $0.25
  • BOF $2.40
  • Resistance Level
  • ERNA $0.37
  • BOF $2.59
  • Average True Range (ATR)
  • ERNA 0.04
  • BOF 0.20
  • MACD
  • ERNA -0.00
  • BOF -0.08
  • Stochastic Oscillator
  • ERNA 54.08
  • BOF 7.50

About ERNA Eterna Therapeutics Inc.

Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

Share on Social Networks: